Qvar
FDA Label NDC 50090-3033

34 label sections · Submitted to the FDA by A-s Medication Solutions · Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by A-s Medication Solutions for the product Qvar (NDC 50090-3033). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding 1 indications and usage, 2.1 administration information, 2.2 recommended dosage, 3 dosage forms and strengths, 4 contraindications, 5.1 local effects, 5.2 deterioration of asthma and acute episodes, 5.3 transferring patients from systemic corticosteroid therapy, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Storage

Store at 25°C (77°F).

* Please review the disclaimer below.